An adult client with type 2 diabetes mellitus receives a prescription for liraglutide 1.2 mg SUBQ daily. The nurse should explain that the purpose of this medication is to obtain which outcome?

Rationale: A. Eliminate the need for insulin: Liraglutide is a GLP-1 receptor agonist that enhances glucose-dependent insulin secretion, but it does not completely replace the need for insulin in all clients. Some individuals with advanced diabetes may still require insulin therapy for adequate control. B. Prevent pancreatic irritability: This medication does not work by reducing pancreatic irritation. Instead, it modulates pancreatic function by increasing insulin secretion and decreasing glucagon release when glucose levels are elevated. C. Improve glycemic control: The primary goal of liraglutide therapy is to improve glycemic control in adults with type 2 diabetes. It lowers fasting and postprandial blood glucose by enhancing insulin secretion, suppressing glucagon, and slowing gastric emptying, thereby reducing hyperglycemia. D. Promote gastric emptying: Liraglutide actually delays gastric emptying rather than promoting it. This slowing of gastric motility helps reduce postprandial glucose spikes, but it is not the main therapeutic outcome.